Let Swissnex take you to Slush! Are you a Swiss early-stage startup or a pre-startup (planning to be incorporated soon) tackling problems related to oncology, novel tools for disease detection and ...

Incorporated in 2024, Zenline AI is already in daily use by leading European retailers and analyzes over 1 million Stock Keeping Units (SKUs). To further strengthen its market position, the startup ...

Zurich-based startup Fashion League is building a mobile-first 3D fashion gaming platform that combines gaming, digital self-expression, and real-world fashion partnerships. With CHF 9.1 million ...

Based in Zug, Previse Systems is a leading provider of next-generation Energy Trading & Risk Management (ETRM) software, serving more than 20 customers, top-tier energy companies. The company now has ...

Following six years of development and testing with early adopters, TALPA-Inspection is ready for commercialization. The company is launching its non-destructive and automated corrosion inspection ...

As of this year, selected startups become official members of the Medtech Innovator program, which includes access to networking opportunities, funding and increased visibility within the medical ...

One year after its inception, catchfree has entered the B2B market with its first plant-only assortment: Fischknusperli and Fish Sticks. Distribution through Swiss gastronomy companies Bianchi and ...

LIVING FILMS., the new project of Geneva-based startup Oovie Studio that merges music, cinema, and artificial intelligence, will make its international debut on Wednesday, September 3, 2025, in the ...

Just three months following its incorporation, Zurich-based CDDS is already making strides with its autonomous kinetic interceptor drones that detect, track and physically neutralize airborne threats.

The Agridence Group, a leader in digital agri-commodity supply chain solutions, announced its acquisition of farmer connect, the Swiss-based compliance and traceability platform. Agridence customers ...

Pilatus Biosciences, a biopharmaceutical company developing novel metabolic checkpoint immunotherapies for liver and gastrointestinal cancers, has entered a clinical trial collaboration with Roche.